Corringham, Robert E.,O'Donnell, Patrick B.,James, Joyce K.,ODonnell, Patrick B.
申请号：
AU2015230806
公开号：
AU2015230806A1
申请日:
2015.09.25
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2015230806A120151015.pdf#####Abstract: Provided herein are methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7- (2morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients, including a specific patient population. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided. 69
